Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer
Clinical trial NCT07732413 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07732413
- Sponsor
- Lumos Pharma
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-08
- Primary completion
- 2030-10-08
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.